A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51691
Abstract: Peripheral neuropathy is a relevant dose‐limiting adverse event that can affect up to 90% of oncologic patients with colorectal cancer receiving oxaliplatin treatment. The severity of neurotoxicity often leads to dose reduction or even premature… read more here.
Keywords: inflammatory response; oxaliplatin neurotoxicity; response contributes; neurotoxicity ... See more keywords